Nordnet AB (publ) (STO:SAVE)

Ligand Pharmaceuticals Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest and Dividend Income	3,177	3,494	3,311	1,663	945.2	787.11
Total Interest Expense	733.3	859.3	671.3	381.8	217.9	183.56
Net Interest Income	2,444	2,635	2,639	1,281	727.3	603.56
Brokerage Commission	3,414	3,069	2,458	2,695	3,476	2,609
Gain on Sale of Investments (Rev)	-9.3	-9.3	-13	-8.1	26.8	-4.06
Other Revenue	54.4	60.4	61.1	85.5	140	59.67
Revenue Before Loan Losses	5,903	5,755	5,145	4,053	4,371	3,269
Provision for Loan Losses	-40	10	79.6	43.4	36.3	38.7
Revenue	5,943	5,745	5,065	4,010	4,334	3,230
Revenue Growth (YoY)	9.59%	13.41%	26.32%	-7.48%	34.19%	76.83%
Salaries & Employee Benefits	-	-	-	-	1.18	-
Cost of Services Provided	2,020	1,934	1,672	1,744	1,673	1,580
Other Operating Expenses	61.3	50.3	59.1	59	36.9	34.58
Total Operating Expenses	2,373	2,268	1,910	1,975	1,874	1,771
Operating Income	3,569	3,476	3,155	2,035	2,460	1,459
Currency Exchange Gains	6.1	6.1	5.3	-0.7	-8.9	-10.16
Other Non-Operating Income (Expenses)	-4	-	-0.2	0.1	-0.1	-
EBT Excluding Unusual Items	3,571	3,482	3,160	2,034	2,451	1,449
Asset Writedown	-	-	-	-	-	-2.38
Pretax Income	3,571	3,482	3,160	2,034	2,451	1,447
Income Tax Expense	691.8	668.8	581.6	381.7	466.5	273.88
Earnings From Continuing Ops.	2,880	2,814	2,579	1,653	1,985	1,173
Net Income	2,880	2,814	2,579	1,653	1,985	1,173
Preferred Dividends & Other Adjustments	66.3	86.3	121.5	65.8	37.7	35.76
Net Income to Common	2,813	2,727	2,457	1,587	1,947	1,137
Net Income Growth	3.25%	9.11%	56.05%	-16.74%	69.24%	245.44%
Shares Outstanding (Basic)	250	251	250	250	250	250
Shares Outstanding (Diluted)	251	251	250	251	251	250
Shares Change (YoY)	0.06%	0.55%	-0.28%	-0.22%	0.46%	-
EPS (Basic)	11.23	10.86	9.83	6.35	7.79	4.55
EPS (Diluted)	11.22	10.85	9.83	6.33	7.75	4.55
EPS Growth	5.24%	10.38%	55.29%	-18.32%	70.41%	263.47%
Free Cash Flow	16,955	6,047	-12,635	6,470	13,566	11,890
Free Cash Flow Per Share	67.60	24.07	-50.56	25.82	54.02	47.56
Dividend Per Share	8.100	8.100	7.200	4.600	5.560	1.510
Dividend Growth	12.50%	12.50%	56.52%	-17.27%	268.21%	-98.84%
Operating Margin	60.06%	60.51%	62.29%	50.74%	56.76%	45.18%
Profit Margin	47.34%	47.48%	48.51%	39.57%	44.92%	35.20%
Free Cash Flow Margin	285.31%	105.26%	-249.44%	161.33%	313.00%	368.12%
Effective Tax Rate	19.37%	19.20%	18.40%	18.76%	19.03%	18.93%

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.